Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein mab-21-like 3 (MAB21L3) is a member of the highly conserved MAB21-like family of nucleotidyltransferase-fold proteins that share structural homology with the cyclic GMP-AMP synthase (cGAS), a sensor of cytosolic DNA in innate immunity[1][2][4]. MAB21L3 is less characterized than MAB21L1 and MAB21L2, but is implicated in cell fate determination during development, especially in the context of multiciliate and ionocyte cell differentiation downstream of Notch signaling in vertebrates[2][4]. The exact molecular function, biochemical activity, and ligand interactions of MAB21L3 remain unknown—unlike cGAS, its nucleotidyltransferase activity has not been demonstrated and may require conformational change for activation, or may be absent[1][2][4]. Mutations in closely related proteins (MAB21L1, MAB21L2) are associated with severe developmental disorders, highlighting the likely crucial, though incompletely defined, role of these proteins in vertebrate development[1][2][4]. No known drugs, biomarkers, or disease associations specific to MAB21L3 are described in the current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein mab-21-like 3 (MAB21L3).